Kansanterveyslaitos KTL

Viitteet 1-1 / 1

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

Villa LL; Costa RLR; Petta CA; Andrade RP; Ault KA; Guiliano AR; Wheeler CM; Koutsky LA; Malm C; Lehtinen M; Skjeldestad FE; Olsson S-E; Steinwall M; Brown DR; Kurman R; Ronnett BM; Stoler MH; Ferenczy A; Harper DM; Tamms GM; Yu J; Lupinacci L; Railkar R; Taddeo FJ; Jansen KU; Esser MT; Sings HL; Saah A; Barr E
Lancet Oncology : 5 (2005)

"Saah A" - Selaus tekijän mukaan Kansanterveyslaitos KTL